The way he sees it, Singapore’s economic reopening is an eventuality, underpinned by the government’s reiterated commitment to continue living with the virus, as well as the ramping up of healthcare capacity and rollout of vaccination booster doses.
RHB Group Research analyst Shekhar Jaiswal has a sanguine outlook for Singapore equities in 2022, despite uncertainties caused by the emergence of the Omicron variant.
“While the emergence of the Omicron variant will create volatility, we believe Singapore offers opportunities to accumulate stocks that leverage on economic re-opening, and counters that now offer better earnings visibility despite macroeconomic risks,” Jaiswal says in a Dec 17 research note.
